tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vir Biotechnology’s Strategic Advancements and Strong Pipeline Drive Buy Rating
PremiumRatingsVir Biotechnology’s Strategic Advancements and Strong Pipeline Drive Buy Rating
1M ago
Vir Biotechnology: Strong Execution and Promising Prospects Justify Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Execution and Promising Prospects Justify Buy Rating
1M ago
Vir Biotechnology’s Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Vir Biotechnology’s Earnings Call Highlights Progress and Challenges
1M ago
Vir Biotechnology enrolls first participant in ECLIPSE 3 trial
PremiumThe FlyVir Biotechnology enrolls first participant in ECLIPSE 3 trial
1M ago
Vir Biotechnology enrolls first patient in ECLIPSE trial
Premium
The Fly
Vir Biotechnology enrolls first patient in ECLIPSE trial
1M ago
Vir Biotechnology Begins Phase 1 Trial for VIR-5525
Premium
Company Announcements
Vir Biotechnology Begins Phase 1 Trial for VIR-5525
2M ago
Vir Biotechnology initiated with an Outperform at Raymond James
PremiumThe FlyVir Biotechnology initiated with an Outperform at Raymond James
2M ago
Vir Biotechnology initiated with an Outperform at Raymond James
Premium
The Fly
Vir Biotechnology initiated with an Outperform at Raymond James
2M ago
Positive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market
Premium
Ratings
Positive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100